Several studies support the effectiveness of hyperbaric oxygen therapy (HBOT) in patients with Parkinson’s disease. Research has shown significant improvements in the symptoms of the disease in patients combined their treatment with hyperbaric chamber treatment: they decreased stiffness and tremors, improved posture and facial expression, as well as better sleep and mobility.
The increase in oxygen in the blood achieved by the hyperbaric chamber (Hyperoxia) produces a series of physiological processes that help the recovery of body tissues, from muscle and bone to neuronal. Hyperbaric Oxygen is anti-inflammatory, distributes blood flow at the level of the Central Nervous System, stimulates the repair of nervous tissues and has effects on neurotransmitters. This combination of effects achieves a remarkable improvement in the clinical picture of the patients, in their quality of life and their emotional state.
Comments are closed.